Erythroid precursor cell maturation process (null)

The erythroid precursor cell maturation process encompasses the progressive development of erythroid cells in the bone marrow from committed progenitors (such as BFU-E, CFU-E, and proerythroblasts) through erythroblast stages (basophilic, polychromatic, orthochromatic), culminating in enucleation to form reticulocytes, which further mature into erythrocytes. This process is tightly regulated by signaling cascades structured around transcription factors (e.g., GATA-1), cytokines (primarily erythropoietin), and cell surface markers (CD34, CD71, CD105, CD36). Defects in maturation can lead to anemia, bone marrow failure, dyserythropoiesis, and are relevant in hematological malignancies. The maturation process itself is not a direct target for therapeutic agents but is modulated via specific molecular targets such as the erythropoietin receptor and associated signaling pathways.

Other names

Erythroid maturationErythroid differentiationErythropoiesis

null (as above; drugs commonly act via stimulation or inhibition of molecular regulators within the process, such as EPO receptor agonists)